CureVac N.V. (5CV.F)
EUR 3.15
(-2.48%)
EUR 3.15
(-2.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 24.82 Million EUR | 3.47% |
| 2022 | 23.98 Million EUR | -57.28% |
| 2021 | 56.15 Million EUR | 286.48% |
| 2020 | 14.53 Million EUR | 134.48% |
| 2019 | 6.19 Million EUR | 110.0% |
| 2018 | 2.95 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 457.26 Thousand EUR | -98.26% |
| 2024 Q1 | 26.2 Million EUR | 5.58% |
| 2023 Q2 | 22.19 Million EUR | -10.07% |
| 2023 FY | 24.82 Million EUR | 3.47% |
| 2023 Q1 | 24.67 Million USD | 2.87% |
| 2023 Q3 | 23.3 Million EUR | 4.98% |
| 2023 Q4 | 24.82 Million EUR | 6.53% |
| 2022 Q3 | 7.86 Million EUR | -40.58% |
| 2022 Q2 | 13.24 Million EUR | -49.3% |
| 2022 Q1 | 26.11 Million EUR | -53.5% |
| 2022 FY | 23.98 Million EUR | -57.28% |
| 2022 Q4 | 23.98 Million EUR | 204.89% |
| 2021 Q4 | 56.15 Million EUR | -60.14% |
| 2021 Q3 | 140.88 Million EUR | 123.93% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 FY | 56.15 Million EUR | 286.48% |
| 2021 Q2 | 62.91 Million EUR | 0.0% |
| 2020 Q1 | 5.42 Million EUR | -12.46% |
| 2020 Q4 | 14.53 Million EUR | 919.0% |
| 2020 Q3 | 1.42 Million EUR | 0.0% |
| 2020 Q2 | - EUR | -100.0% |
| 2020 FY | 14.53 Million EUR | 134.48% |
| 2019 Q1 | - EUR | 0.0% |
| 2019 FY | 6.19 Million EUR | 110.0% |
| 2019 Q4 | 6.19 Million EUR | 0.0% |
| 2018 FY | 2.95 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| BioNTech SE | 357.7 Million EUR | 93.061% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 94.077% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 94.077% |
| BRAIN Biotech AG | 9.72 Million EUR | -155.207% |
| Formycon AG | 467 Thousand EUR | -5215.085% |
| Heidelberg Pharma AG | 10.48 Million EUR | -136.67% |
| Medigene AG | 1.00 EUR | -2482144600.0% |